News
-
Illumina wins UK round of global patent battle against BGI
Genomics giant Illumina, which has major research facilities in Cambridge, has won a UK patent infringement case against BGI Companies. The High... Read More
-
Treatt profit forecast sends share price skywards
Shares in Suffolk-based manufacturer Treatt plc rocketed 100p – around 13 per cent – to 870p in UK trading today after stunning profit news in a... Read More
-
2020 brings record company formations for Cambridgeshire despite pandemic
More new businesses were established in Cambridgeshire during 2020 than in any previous year – hitting a new record high. Despite the considerable... Read More
-
Cambridge life science deals worth more than $50 billion over the last 12 calendar months
Deals valued at over £1 million in the East of England life science cluster in the last 12 calendar months totalled $50.371 billion – and that doesn’... Read More
-
UK-US alliance targets chronic pancreatitis
Cambridge rare diseases pathfinder Healx is combining its AI and drug discovery expertise with US-powered Mission: Cure’s disease knowledge and... Read More
-
Spotta expands into £multibillion insect pest markets
Hi-tech pest control business Spotta has capped a strong first year of commercial operations with accelerated product development and market reach... Read More
-
Kier fightback continues with £200 million Transport for London contract
A swell of orders at the back end of 2020 and the start of the New Year has stirred hopes of a return to former glories for East of England... Read More
-
Plans approved for second phase of Icon Harlow logistics development
Icon Industrial, a strategic joint venture by leading commercial property developer Stoford Developments and private global investment firm TPG Real... Read More
-
Cambridge Belfry back to the future with relaunch
The Cambridge Belfry is going back to its roots and relaunching as an individual hotel. The relaunch comes as it decouples from the Hilton... Read More
-
Back on top after being Down Under
Business and financial adviser Grant Thornton has appointed Mike Tillson as partner in its corporate finance advisory team, to work across the... Read More
-
IFF creates ‘new company for new era’
The $45.4 billion merger of International Flavours & Fragrances with Dupont’s Nutrition & Biosciences business will create a “new company for... Read More
-
Cambridge Pixel radar technology closes net on pirates and smugglers
Cambridge Pixel, a developer of radar display, tracking and recording sub-systems, has opened up new markets with a fresh technology uptick. The... Read More
-
Pre-purchase deals give AstraZeneca COVID vaccine the global edge
New research shows that while pharma giants BioNTech-Pfizer and Moderna will earn $14.7 billion from sales of their COVID-19 vaccines in the next two... Read More
-
100 per cent renewable energy confirmed for new JM battery facility in Poland
Johnson Matthey, the Cambridge Cluster-based world leader in sustainable technologies, says its battery cathode materials plant in Konin, Poland,... Read More
-
Lotus boosts jobs and production with new Norwich facility
The first extruded and bonded aluminium chassis to be built at Lotus’ new manufacturing facility at Hurricane Way, Norwich, has been completed.... Read More
-
California’s Apricot a tasty acquisition for SPT Labtech
Cambridge’s SPT Labtech has paid an undisclosed sum for a California based global leader in the design and development of automated instrumentation... Read More
-
Chatrath leaves Secondmind to foster fresh technology startups
Co-founder and CEO Vishal Chatrath has sent shock waves through the Cambridge UK technology community by quitting his role with Secondmind.ai –... Read More
-
Kymab the 20th Cambridge business to notch $bn valuation
Kymab’s $1.45 billion acquisition by French heavyweight Sanofi brought the total of Cambridge-born companies with a billion dollar valuation to a new... Read More
-
LifeArc and Metrion extend neuroscience drug discovery collaboration
Metrion Biosciences, a Cambridge ion channel CRO and drug discovery company, and medical research charity LifeArc have extended a neuroscience drug... Read More
-
AstraZeneca hails US approval for gastric cancer medicine
The first HER2-directed medicine approved for patients with gastric cancer in a decade – piloted by Cambridge’s AstraZeneca and Daiichi Sankyo – has... Read More